Sirolimus DCBs in PAD and CLTI: Three Studies Add Support mosbey@crf.org Tue, 10/06/2026 - 17:04 L.A. McKeown The evolving data now show clear biological efficacy with impact on hard clinical outcomes, says Sahil Parikh.

Poor Cognitive Scores for Adults in Their 60s Portend Higher Stroke Risk mosbey@crf.org Tue, 10/06/2026 - 14:47 Yael L. Maxwell The observational Swedish data need to be further explored but may have identified a new screening target in stroke prevention.

A key message is that clinicians need to include nutrition discussions as part of routine care, Frank Hu says.

EACTS 2026: What to Expect in Barcelona mosbey@crf.org Mon, 10/05/2026 - 14:04 Yael L. Maxwell This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

VIVA 2026: What to Expect in Las Vegas mosbey@crf.org Mon, 10/05/2026 - 11:42 L.A. McKeown From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.

ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of AI-ECG.

Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.

HRT for Menopause and CV Risk: Two Observational Studies Provide Insights mosbey@crf.org Fri, 10/02/2026 - 16:36 Yael L. Maxwell Timing of treatment and formulation matter, but much remains unknown.

FDA Approves First Expandable Option for Pediatric Patients With Pulmonary Valve Disease mosbey@crf.org Fri, 10/02/2026 - 16:03 Caitlin E. Cox The Autus surgically implanted device, made by Edwards Lifesciences, is also novel for its leaflets consisting of ePTFE.

ACC Statement Underscores Importance of Healthy Eating for Managing CVD mosbey@crf.org Fri, 10/02/2026 - 14:42 Todd Neale A key message is that clinicians need to include nutrition discussions as part of routine care, Frank Hu says.

Over the last 25 years, there have been low rates of device failures and death in patients who received an ICD.

More Data Affirm No Cognitive Benefits of Carotid Revascularization: CREST-2 mosbey@crf.org Thu, 10/01/2026 - 15:10 L.A. McKeown Experts urge clinicians to focus on stroke prevention benefits when counseling patients about carotid revascularization.

FDA Expands Mavacamten Indication to Pediatric Obstructive HCM Patients mosbey@crf.org Thu, 10/01/2026 - 13:24 Caitlin E. Cox

This month: Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.

TCTMD’s Top 10 Most Popular Stories for September 2026 mosbey@crf.org Wed, 09/30/2026 - 13:00 Caitlin E. Cox ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of AI-ECG.

Top Cardiology News for September 2026 mosbey@crf.org Wed, 09/30/2026 - 09:54 1 hour 16 minutes hence This month, the TCTMD team's picks spotlight the big picture: TAVI reimbursement, a cardiology-focused AI initiative, volume requirements for interventionalists, and the Fifth UDMI

The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

Heart Failure Clinics Often Missing Where They’re Most Needed: HFSA Report mosbey@crf.org Tue, 09/29/2026 - 16:28 Todd Neale Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.

MACE risk appeared to be higher in cases for which there was disagreement, perhaps identifying the need for a closer look.

Multimodality Imaging May Better Stratify MACE Risk in Myocarditis mosbey@crf.org Mon, 09/28/2026 - 17:10 Caitlin E. Cox A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.

The largest ethnic minority in the US faces earlier disease onset along with access issues and misconceptions about prevention.

The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ignored.

Leaders call for removal of this outdated metric, which they say has no bearing over ongoing interventional cardiologist quality.

TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.

Seamlessly merging the AHA’s new CV risk calculators into the country’s largest electronic health record system marks a big win.

Recurrent Stroke Rates Low 15 Years After PFO Closure mosbey@crf.org Fri, 09/25/2026 - 11:21 Todd Neale The findings align with the PROLONG registry and bolster evidence for limiting the duration of antithrombotic therapy.

Task force members emphasize the STAMP method: Screen, Triage, Address risk, Modify management, and Plan services.

AHA Statement Addresses Gaps in Hispanic CVD Care mosbey@crf.org Thu, 09/24/2026 - 13:00 L.A. McKeown The largest ethnic minority in the US faces earlier disease onset along with access issues and misconceptions about prevention.

Premature heart disease in men and women in this population stands out in a way that it doesn’t in other ethnic groups.

From February 2026: Roxana Mehran speaks with Ami Bhatt and Rohan Khera about how artificial intelligence will transform cardiology.

HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are introduced.

More Strokes, Especially Ischemic, With LAAO vs Medical Therapy: Meta-analysis mosbey@crf.org Wed, 09/23/2026 - 15:20 Yael L. Maxwell A drop in hemorrhagic stroke with the procedure, however, may counterbalance the findings, the authors say.

Rox Heart Replay: Why AI? mosbey@crf.org Wed, 09/23/2026 - 10:12 49 minutes 15 seconds ago From February 2026: Roxana Mehran speaks with Ami Bhatt and Rohan Khera about how artificial intelligence will transform cardiology.

‘Moderate’ Agreement Between AI and Heart Team for Complex CAD Decisions mosbey@crf.org Tue, 09/22/2026 - 15:57 Todd Neale MACE risk appeared to be higher in cases for which there was disagreement, perhaps identifying the need for a closer look.

September 2026 Dispatch for the CV Team mosbey@crf.org Tue, 09/22/2026 - 09:50 L.A. McKeown This month: Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.

Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab infrastructure.

The approval gives US operators a second DCB option after Agent entered the market 2-and-a-half years ago.

Outcomes Steady as Hearts Donated After Circulatory Death Rise in the US mosbey@crf.org Mon, 09/21/2026 - 15:42 Caitlin E. Cox The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ignored.

FDA Approves Selution SLR Drug-Eluting Balloon for Coronary In-Stent Restenosis mosbey@crf.org Mon, 09/21/2026 - 15:26 Todd Neale The approval gives US operators a second DCB option after Agent entered the market 2-and-a-half years ago.

The latest UDMI aims to align classifications with pathology and clinical practice, bringing numerous changes to the 2018 version.

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

(UPDATED) Asymptomatic patients will now be covered and more flexibility has been given to heart teams for individualizing patient care.